8 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... in HFrEF on GDMT ... outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ejection fraction; GDMT ... HFpEF, heart failure ... ejection fraction; HFrEF ... #CHF #Congestive ... ACCAHA #Algorithm #Management
Diagnostic Algorithm for Treatment of Iron Deficiency in Patients With Heart Failure 

Consensus Recommendations 

#Iron #Deficiency
Diagnostic Algorithm ... Patients With Heart Failure ... #Deficiency #Management ... #HFrEF #sCHF #HeartFailure ... #Indications #Treatment
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
, haemoglobin; HFrEF ... #Deficiency #Management ... #Diagnosis #HFrEF ... #sCHF #HeartFailure ... #Cardiology #Indications
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
in Heart Failure ... patients with HFrEF ... #deficiency #CHF ... #HFrEF #heartfailure ... #diagnosis #management
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... Ejection Fraction (HFrEF ... patients with HFrEF ... #HFrEF #Pharmacology ... #Management #Treatment
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
in Heart Failure ... mortality and CV ... #deficiency #CHF ... #HFrEF #heartfailure ... #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
disease b) CHF ... the type of and indication ... CARP, DECREASE V trials ... medical and surgical management ... stratification #diagnosis